BALLARD PARTNERS

Lobbying for ALKERMES, INC. · Biopharmaceutical company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 12, 2026

Income

$140,000.00

What the client paid this registrant for the period.

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Provide guidance and advice regarding mental health, public health and regulatory reform.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.